Oyavas 100 mg/4 ml

Oyavas 100 mg/4 ml is a medicine authorised by Swissmedic under authorisation number 67857. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 04 June 2021 and the authorisation is valid without a time limit. ATC code L01FG01 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 67857
  • ATC L01FG01
  • Biotechnological medicines
Authorisation data
Authorisation number67857
NameOyavas 100 mg/4 ml
Full nameOyavas 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderSpirig HealthCare AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01FG01
First authorisation04 June 2021
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Oyavas 100 mg/4 ml, Konzentrat zur Herstellung einer InfusionslösungA04 June 2021
2Oyavas 400 mg/16 ml, Konzentrat zur Herstellung einer InfusionslösungA04 June 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01FG0107.16.1.A
21Durchstechflasche(n)L01FG0107.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Oyavas 100 mg/4 ml authorised in Switzerland?

Yes. Oyavas 100 mg/4 ml is authorised by Swissmedic under authorisation number 67857, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Oyavas 100 mg/4 ml have?

Oyavas 100 mg/4 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Oyavas 100 mg/4 ml?

The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com